Sinopharm introduces Artesunate injection on Ghanaian market

Sinopharm Ghana Limited, a leading pharmaceutical company in the country has launched a new product known as Artesunate for Injection into Ghana’s competitive pharmaceutical industry. The Marketing Manager of the company, Mr. Daniel Djameh, who performed the launch in Accra, said, “Artesunate Injection is the preferred choice in the initial treatment of malaria.” He noted that the treatment objective of Artesunate for Injection was able to prevent patients from dying, and was water soluble, as well as clearing mosquito parasite, fever and coma recovery. Mr. Djameh appealed to people to purchase the product, so to reduce the number of malaria deaths in the country.